ALXO - ALX Oncology Announces September Investor Conference Participation | Benzinga
SOUTH SAN FRANCISCO, Calif., Aug. 31, 2023 (GLOBE NEWSWIRE) -- ALX Oncology Holdings Inc., ("ALX Oncology") (NASDAQ:ALXO), a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that management will participate in two upcoming investor conferences.
H.C. Wainwright 25th Annual Global Investment Conference
Format: Fireside chat with analyst, Swayampakula Ramakanth
Date: Monday, September 11
Time: 2:30 PM Eastern Time
Location: New York, NY
Webcast link: Available here
2023 Cantor Global Healthcare Conference
Format: Fireside chat with analyst, Li Watsek
Date: Tuesday, September 26
Time: 9:10 AM Eastern Time
Location: New York, NY
Webcast link: Available here
The live webcasts for the H.C. Wainwright and Cantor fireside chats can be accessed by visiting the Investors section of ALX Oncology's website at www.alxoncology.com and selecting Events under the News and Events ...